» Authors » Martina Milella

Martina Milella

Explore the profile of Martina Milella including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 288
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lucarelli G, Lasorsa F, Milella M, dAmati A, Ingravallo G, Silecchia M, et al.
Urol Oncol . 2025 Mar; PMID: 40082108
Background: Pathological grade is a morphological parameter of clear cell-renal cell carcinoma (ccRCC) and an independent predictor of cancer-specific survival. The aim of this study was to identify grade-dependent metabolic...
2.
Lasorsa F, Rutigliano M, Milella M, dAmati A, Crocetto F, Pandolfo S, et al.
Int J Mol Sci . 2024 Apr; 25(8). PMID: 38673917
Kidney transplantation offers a longer life expectancy and a better quality of life than dialysis to patients with end-stage kidney disease. Ischemia-reperfusion injury (IRI) is thought to be a cornerstone...
3.
Milella M, Rutigliano M, Lasorsa F, Ferro M, Bianchi R, Fallara G, et al.
Biomolecules . 2024 Mar; 14(3). PMID: 38540735
Mucins are a family of high-molecular-weight glycoproteins. MUC1 is widely studied for its role in distinct types of cancers. In many human epithelial malignancies, MUC1 is frequently overexpressed, and its...
4.
Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo S, Crocetto F, et al.
Int J Mol Sci . 2023 Nov; 24(22). PMID: 38003705
The crosstalk among the complement system, immune cells, and mediators of inflammation provides an efficient mechanism to protect the organism against infections and support the repair of damaged tissues. Alterations...
5.
Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo S, Crocetto F, et al.
Int J Mol Sci . 2023 Sep; 24(17). PMID: 37685983
The term "cancer stem cell" (CSC) refers to a cancer cell with the following features: clonogenic ability, the expression of stem cell markers, differentiation into cells of different lineages, growth...
6.
Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo S, Crocetto F, et al.
J Clin Med . 2023 Jun; 12(12). PMID: 37373581
Globally, clear-cell renal cell carcinoma (ccRCC) represents the most prevalent type of kidney cancer. Surgery plays a key role in the treatment of this cancer, although one third of patients...
7.
Fanizzi A, Graps E, Bavaro D, Farella M, Bove S, Campobasso F, et al.
BMC Health Serv Res . 2023 May; 23(1):526. PMID: 37221516
Background: A timely diagnosis is essential for improving breast cancer patients' survival and designing targeted therapeutic plans. For this purpose, the screening timing, as well as the related waiting lists,...
8.
Lasorsa F, di Meo N, Rutigliano M, Milella M, Ferro M, Pandolfo S, et al.
Biomedicines . 2023 May; 11(4). PMID: 37189689
Renal cell carcinoma (RCC) is the seventh most common cancer in men and the ninth most common cancer in women worldwide. There is plenty of evidence about the role of...
9.
di Meo N, Lasorsa F, Rutigliano M, Milella M, Ferro M, Battaglia M, et al.
Expert Rev Mol Diagn . 2023 Mar; 23(4):297-313. PMID: 36960789
Introduction: Lipidomics focuses on the in-depth analysis of lipids, which are crucial macromolecules involved in a wide range of metabolic pathways. The increased intracellular accumulation of different classes of lipids...
10.
Lucarelli G, Netti G, Rutigliano M, Lasorsa F, Loizzo D, Milella M, et al.
Int J Mol Sci . 2023 Mar; 24(5). PMID: 36902242
Mucin1 (MUC1), a glycoprotein associated with an aggressive cancer phenotype and chemoresistance, is aberrantly overexpressed in a subset of clear cell renal cell carcinoma (ccRCC). Recent studies suggest that MUC1...